

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.41287963 |
| 2 | drug catabolic process (GO:0042737) | 8.51007672 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 8.05071267 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 6.90141140 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.90141140 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 6.60943516 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.60943516 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.34813449 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.92100618 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.92100618 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.92100618 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.80582625 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.79141173 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.69129966 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.65585507 |
| 16 | drug metabolic process (GO:0017144) | 5.62041716 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.55472607 |
| 18 | complement activation, alternative pathway (GO:0006957) | 5.49332428 |
| 19 | opsonization (GO:0008228) | 5.46030522 |
| 20 | blood coagulation, intrinsic pathway (GO:0007597) | 5.35990372 |
| 21 | oxidative demethylation (GO:0070989) | 5.35931872 |
| 22 | glyoxylate metabolic process (GO:0046487) | 5.33131609 |
| 23 | regulation of protein activation cascade (GO:2000257) | 5.28871264 |
| 24 | urea cycle (GO:0000050) | 5.26209332 |
| 25 | urea metabolic process (GO:0019627) | 5.26209332 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.24109654 |
| 27 | glucocorticoid biosynthetic process (GO:0006704) | 5.17403988 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.12766266 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.04530225 |
| 30 | protein carboxylation (GO:0018214) | 5.04530225 |
| 31 | negative regulation of fibrinolysis (GO:0051918) | 5.04409202 |
| 32 | regulation of complement activation (GO:0030449) | 5.02486503 |
| 33 | regulation of plasminogen activation (GO:0010755) | 4.96016105 |
| 34 | cysteine metabolic process (GO:0006534) | 4.92321241 |
| 35 | regulation of humoral immune response (GO:0002920) | 4.91124226 |
| 36 | regulation of fibrinolysis (GO:0051917) | 4.90447216 |
| 37 | high-density lipoprotein particle remodeling (GO:0034375) | 4.90196289 |
| 38 | negative regulation of protein activation cascade (GO:2000258) | 4.89772873 |
| 39 | bile acid metabolic process (GO:0008206) | 4.84793618 |
| 40 | nitrogen cycle metabolic process (GO:0071941) | 4.84216391 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.82665627 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 4.68968604 |
| 43 | coenzyme catabolic process (GO:0009109) | 4.65602347 |
| 44 | acute-phase response (GO:0006953) | 4.61287932 |
| 45 | ethanol metabolic process (GO:0006067) | 4.60784771 |
| 46 | acylglycerol homeostasis (GO:0055090) | 4.60432022 |
| 47 | triglyceride homeostasis (GO:0070328) | 4.60432022 |
| 48 | aromatic amino acid family metabolic process (GO:0009072) | 4.59163849 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 4.52154138 |
| 50 | negative regulation of hemostasis (GO:1900047) | 4.51375277 |
| 51 | negative regulation of blood coagulation (GO:0030195) | 4.51375277 |
| 52 | lysine metabolic process (GO:0006553) | 4.50481437 |
| 53 | lysine catabolic process (GO:0006554) | 4.50481437 |
| 54 | homocysteine metabolic process (GO:0050667) | 4.45032957 |
| 55 | tyrosine metabolic process (GO:0006570) | 4.40366502 |
| 56 | alpha-amino acid catabolic process (GO:1901606) | 4.39556217 |
| 57 | regulation of apoptotic cell clearance (GO:2000425) | 4.39375094 |
| 58 | reverse cholesterol transport (GO:0043691) | 4.38513626 |
| 59 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.35601157 |
| 60 | phenylpropanoid metabolic process (GO:0009698) | 4.33819855 |
| 61 | protein-lipid complex remodeling (GO:0034368) | 4.30828201 |
| 62 | macromolecular complex remodeling (GO:0034367) | 4.30828201 |
| 63 | plasma lipoprotein particle remodeling (GO:0034369) | 4.30828201 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 4.29031870 |
| 65 | ethanol oxidation (GO:0006069) | 4.23767812 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 4.23270440 |
| 67 | S-adenosylmethionine metabolic process (GO:0046500) | 4.22468691 |
| 68 | regulation of cholesterol esterification (GO:0010872) | 4.21013322 |
| 69 | intestinal cholesterol absorption (GO:0030299) | 4.18104344 |
| 70 | phospholipid efflux (GO:0033700) | 4.16242742 |
| 71 | negative regulation of coagulation (GO:0050819) | 4.15323171 |
| 72 | negative regulation of wound healing (GO:0061045) | 4.13512783 |
| 73 | cellular ketone body metabolic process (GO:0046950) | 4.12754545 |
| 74 | cellular amino acid catabolic process (GO:0009063) | 4.10671546 |
| 75 | bile acid and bile salt transport (GO:0015721) | 4.06543600 |
| 76 | amine catabolic process (GO:0009310) | 4.05571490 |
| 77 | cellular biogenic amine catabolic process (GO:0042402) | 4.05571490 |
| 78 | cellular glucuronidation (GO:0052695) | 4.03992621 |
| 79 | imidazole-containing compound metabolic process (GO:0052803) | 4.03396049 |
| 80 | androgen biosynthetic process (GO:0006702) | 4.03126581 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 4.01220035 |
| 82 | acetyl-CoA metabolic process (GO:0006084) | 3.99131610 |
| 83 | cytolysis (GO:0019835) | 3.98561614 |
| 84 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.96921143 |
| 85 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.96921143 |
| 86 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.94597690 |
| 87 | polyketide metabolic process (GO:0030638) | 3.93372371 |
| 88 | doxorubicin metabolic process (GO:0044598) | 3.93372371 |
| 89 | daunorubicin metabolic process (GO:0044597) | 3.93372371 |
| 90 | negative regulation of cholesterol transport (GO:0032375) | 3.92529506 |
| 91 | negative regulation of sterol transport (GO:0032372) | 3.92529506 |
| 92 | negative regulation of complement activation (GO:0045916) | 3.92462017 |
| 93 | fatty acid beta-oxidation (GO:0006635) | 3.89340486 |
| 94 | benzene-containing compound metabolic process (GO:0042537) | 3.89210526 |
| 95 | glucocorticoid metabolic process (GO:0008211) | 3.89048097 |
| 96 | hormone catabolic process (GO:0042447) | 3.88143765 |
| 97 | glycine metabolic process (GO:0006544) | 3.87398173 |
| 98 | positive regulation of lipid catabolic process (GO:0050996) | 3.86857152 |
| 99 | cholesterol efflux (GO:0033344) | 3.83198223 |
| 100 | glutamate metabolic process (GO:0006536) | 3.82531241 |
| 101 | fatty acid oxidation (GO:0019395) | 3.81558110 |
| 102 | phospholipid homeostasis (GO:0055091) | 3.81004499 |
| 103 | positive regulation of blood coagulation (GO:0030194) | 3.78676444 |
| 104 | positive regulation of hemostasis (GO:1900048) | 3.78676444 |
| 105 | short-chain fatty acid metabolic process (GO:0046459) | 3.77169515 |
| 106 | complement activation, classical pathway (GO:0006958) | 3.76063025 |
| 107 | lipid oxidation (GO:0034440) | 3.75288634 |
| 108 | valine metabolic process (GO:0006573) | 3.75116240 |
| 109 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.73741538 |
| 110 | organic acid catabolic process (GO:0016054) | 3.73301638 |
| 111 | carboxylic acid catabolic process (GO:0046395) | 3.73301638 |
| 112 | complement activation (GO:0006956) | 3.72482262 |
| 113 | flavonoid metabolic process (GO:0009812) | 3.72152623 |
| 114 | serine family amino acid metabolic process (GO:0009069) | 3.71169576 |
| 115 | fatty acid catabolic process (GO:0009062) | 3.68708590 |
| 116 | negative regulation of lipase activity (GO:0060192) | 3.67834547 |
| 117 | response to mercury ion (GO:0046689) | 3.66977273 |
| 118 | cofactor catabolic process (GO:0051187) | 3.66737585 |
| 119 | monocarboxylic acid catabolic process (GO:0072329) | 3.64973154 |
| 120 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.64524288 |
| 121 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.64524288 |
| 122 | fibrinolysis (GO:0042730) | 3.64236966 |
| 123 | plasma lipoprotein particle assembly (GO:0034377) | 3.59066952 |
| 124 | low-density lipoprotein particle remodeling (GO:0034374) | 3.58808605 |
| 125 | 2-oxoglutarate metabolic process (GO:0006103) | 3.58513093 |
| 126 | protein activation cascade (GO:0072376) | 3.58199586 |
| 127 | ketone body metabolic process (GO:1902224) | 3.56807172 |
| 128 | xenobiotic metabolic process (GO:0006805) | 3.56232950 |
| 129 | uronic acid metabolic process (GO:0006063) | 3.53739232 |
| 130 | glucuronate metabolic process (GO:0019585) | 3.53739232 |
| 131 | arginine metabolic process (GO:0006525) | 3.53080168 |
| 132 | epoxygenase P450 pathway (GO:0019373) | 3.52865279 |
| 133 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.52334119 |
| 134 | cholesterol homeostasis (GO:0042632) | 3.51862657 |
| 135 | positive regulation of coagulation (GO:0050820) | 3.51653038 |
| 136 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.51523879 |
| 137 | regulation of cholesterol homeostasis (GO:2000188) | 3.50180175 |
| 138 | fatty acid transmembrane transport (GO:1902001) | 3.47388651 |
| 139 | androgen metabolic process (GO:0008209) | 3.45596304 |
| 140 | alkaloid metabolic process (GO:0009820) | 3.45358826 |
| 141 | regulation of acute inflammatory response (GO:0002673) | 3.44235546 |
| 142 | acute inflammatory response (GO:0002526) | 3.33816557 |
| 143 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.30907661 |
| 144 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.30212479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.75485355 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.66943394 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.48123041 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.18707643 |
| 5 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.00173282 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.99537703 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.41334763 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.18325726 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.42481610 |
| 10 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.58487976 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.34775586 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.8054375 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.91992586 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.80379588 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76516406 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.66341376 |
| 17 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62921245 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.41813011 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41119773 |
| 20 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.35152464 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.34592537 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27543068 |
| 23 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21594656 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20706755 |
| 25 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17720084 |
| 26 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17616344 |
| 27 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10927615 |
| 28 | CJUN_26792858_Chip-Seq_BT549_Human | 1.08937852 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08291118 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07203031 |
| 31 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02915515 |
| 32 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01002878 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95981921 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95176334 |
| 35 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93881979 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93881196 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93615089 |
| 38 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.91714852 |
| 39 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90812583 |
| 40 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90204706 |
| 41 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88630283 |
| 42 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.88534562 |
| 43 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.88143762 |
| 44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87759066 |
| 45 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87679419 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.86381069 |
| 47 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85343002 |
| 48 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.84640872 |
| 49 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84412740 |
| 50 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84412740 |
| 51 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82223666 |
| 52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.80432531 |
| 53 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80085024 |
| 54 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78736452 |
| 55 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78291964 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77966337 |
| 57 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77510680 |
| 58 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74243559 |
| 59 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.73654359 |
| 60 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.73236533 |
| 61 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.72198215 |
| 62 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.71902594 |
| 63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71279805 |
| 64 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.70351654 |
| 65 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.69951710 |
| 66 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.69683199 |
| 67 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.69490605 |
| 68 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.69422246 |
| 69 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.68703729 |
| 70 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.68403749 |
| 71 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.67423030 |
| 72 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.66927884 |
| 73 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.66821590 |
| 74 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.66768928 |
| 75 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.66068381 |
| 76 | NFYA_21822215_ChIP-Seq_K562_Human | 0.65030873 |
| 77 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.64564014 |
| 78 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.64066212 |
| 79 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.62836652 |
| 80 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.62752439 |
| 81 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.62697473 |
| 82 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.62674569 |
| 83 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60908339 |
| 84 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60340543 |
| 85 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.59020023 |
| 86 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.58818213 |
| 87 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.58218515 |
| 88 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57894514 |
| 89 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.57787131 |
| 90 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.56920475 |
| 91 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.55821681 |
| 92 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.55821681 |
| 93 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55704424 |
| 94 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.55546783 |
| 95 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55528052 |
| 96 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.55196314 |
| 97 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55193041 |
| 98 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.54760406 |
| 99 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.54633815 |
| 100 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.54405349 |
| 101 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.53615134 |
| 102 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.53615134 |
| 103 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.53599582 |
| 104 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53074662 |
| 105 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.53053593 |
| 106 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.52766303 |
| 107 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.52533165 |
| 108 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52082909 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.51161078 |
| 110 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.51020522 |
| 111 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.50776372 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.50521369 |
| 113 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.47705990 |
| 114 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47277237 |
| 115 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.47275487 |
| 116 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45739311 |
| 117 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.45165461 |
| 118 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.45156150 |
| 119 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.44140309 |
| 120 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43232787 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42399639 |
| 122 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.41874181 |
| 123 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.41349932 |
| 124 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.41207822 |
| 125 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.41143654 |
| 126 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40950945 |
| 127 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40376727 |
| 128 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.40066294 |
| 129 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.39880555 |
| 130 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.39855891 |
| 131 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.39671643 |
| 132 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39196133 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39105289 |
| 134 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.39093388 |
| 135 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.39020301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.02467756 |
| 2 | MP0005360_urolithiasis | 6.91284897 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.09233753 |
| 4 | MP0005365_abnormal_bile_salt | 6.08145912 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.62811110 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.10260684 |
| 7 | MP0003252_abnormal_bile_duct | 3.91911284 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.74323041 |
| 9 | MP0009840_abnormal_foam_cell | 2.82539574 |
| 10 | MP0005083_abnormal_biliary_tract | 2.80889419 |
| 11 | MP0005332_abnormal_amino_acid | 2.60952733 |
| 12 | MP0003195_calcinosis | 2.57568783 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.36910543 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.36802635 |
| 15 | MP0002118_abnormal_lipid_homeostasis | 2.28228143 |
| 16 | MP0000609_abnormal_liver_physiology | 2.21004659 |
| 17 | MP0005670_abnormal_white_adipose | 2.09212353 |
| 18 | MP0005319_abnormal_enzyme/_coenzyme | 1.88893723 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 1.88619050 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.75428065 |
| 21 | MP0003868_abnormal_feces_composition | 1.72624951 |
| 22 | MP0001764_abnormal_homeostasis | 1.55879140 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55832245 |
| 24 | MP0004130_abnormal_muscle_cell | 1.53762836 |
| 25 | MP0009697_abnormal_copulation | 1.53034148 |
| 26 | MP0003011_delayed_dark_adaptation | 1.50808945 |
| 27 | MP0002254_reproductive_system_inflammat | 1.41258036 |
| 28 | MP0004272_abnormal_basement_membrane | 1.40871955 |
| 29 | MP0003186_abnormal_redox_activity | 1.34336397 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 1.33002414 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.31182294 |
| 32 | MP0005647_abnormal_sex_gland | 1.29516094 |
| 33 | MP0005666_abnormal_adipose_tissue | 1.23714338 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.20751454 |
| 35 | MP0005023_abnormal_wound_healing | 1.20329772 |
| 36 | MP0002971_abnormal_brown_adipose | 1.19605973 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.19152426 |
| 38 | MP0001915_intracranial_hemorrhage | 1.10578141 |
| 39 | MP0000598_abnormal_liver_morphology | 1.09569199 |
| 40 | MP0009764_decreased_sensitivity_to | 1.07773914 |
| 41 | MP0005334_abnormal_fat_pad | 1.05131161 |
| 42 | MP0010368_abnormal_lymphatic_system | 1.02197566 |
| 43 | MP0005451_abnormal_body_composition | 1.01327206 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 1.01122620 |
| 45 | MP0008004_abnormal_stomach_pH | 0.99567658 |
| 46 | MP0002909_abnormal_adrenal_gland | 0.98790987 |
| 47 | MP0009763_increased_sensitivity_to | 0.98666676 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 0.96341321 |
| 49 | MP0002078_abnormal_glucose_homeostasis | 0.96173280 |
| 50 | MP0001661_extended_life_span | 0.92049608 |
| 51 | MP0005535_abnormal_body_temperature | 0.91367991 |
| 52 | MP0003690_abnormal_glial_cell | 0.85691240 |
| 53 | MP0009780_abnormal_chondrocyte_physiolo | 0.84183903 |
| 54 | MP0009642_abnormal_blood_homeostasis | 0.82515055 |
| 55 | MP0003566_abnormal_cell_adhesion | 0.81184374 |
| 56 | MP0005376_homeostasis/metabolism_phenot | 0.81109888 |
| 57 | MP0008469_abnormal_protein_level | 0.79277717 |
| 58 | MP0000604_amyloidosis | 0.78513949 |
| 59 | MP0009115_abnormal_fat_cell | 0.78258834 |
| 60 | MP0005636_abnormal_mineral_homeostasis | 0.77382527 |
| 61 | MP0005266_abnormal_metabolism | 0.76830122 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 0.75226284 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 0.75106103 |
| 64 | MP0003950_abnormal_plasma_membrane | 0.74671425 |
| 65 | MP0003879_abnormal_hair_cell | 0.73875559 |
| 66 | MP0005448_abnormal_energy_balance | 0.73583351 |
| 67 | MP0009765_abnormal_xenobiotic_induced | 0.69273348 |
| 68 | MP0005375_adipose_tissue_phenotype | 0.67752823 |
| 69 | MP0002132_abnormal_respiratory_system | 0.66965648 |
| 70 | MP0005084_abnormal_gallbladder_morpholo | 0.65563667 |
| 71 | MP0002970_abnormal_white_adipose | 0.64257396 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 0.63297553 |
| 73 | MP0005220_abnormal_exocrine_pancreas | 0.60173796 |
| 74 | MP0008438_abnormal_cutaneous_collagen | 0.60115594 |
| 75 | MP0002282_abnormal_trachea_morphology | 0.59372418 |
| 76 | MP0005464_abnormal_platelet_physiology | 0.58748440 |
| 77 | MP0003724_increased_susceptibility_to | 0.58535508 |
| 78 | MP0004381_abnormal_hair_follicle | 0.58407050 |
| 79 | MP0005408_hypopigmentation | 0.57721681 |
| 80 | MP0001756_abnormal_urination | 0.57559430 |
| 81 | MP0005187_abnormal_penis_morphology | 0.55867961 |
| 82 | MP0002928_abnormal_bile_duct | 0.54143133 |
| 83 | MP0005257_abnormal_intraocular_pressure | 0.53321566 |
| 84 | MP0003953_abnormal_hormone_level | 0.49681679 |
| 85 | MP0002168_other_aberrant_phenotype | 0.48535768 |
| 86 | MP0000639_abnormal_adrenal_gland | 0.47977786 |
| 87 | MP0003279_aneurysm | 0.47760534 |
| 88 | MP0002128_abnormal_blood_circulation | 0.46634036 |
| 89 | MP0002269_muscular_atrophy | 0.46481756 |
| 90 | MP0003941_abnormal_skin_development | 0.46286096 |
| 91 | MP0002332_abnormal_exercise_endurance | 0.45676750 |
| 92 | MP0005058_abnormal_lysosome_morphology | 0.44200457 |
| 93 | MP0005395_other_phenotype | 0.44024507 |
| 94 | MP0005248_abnormal_Harderian_gland | 0.43508190 |
| 95 | MP0003959_abnormal_lean_body | 0.42972350 |
| 96 | MP0008874_decreased_physiological_sensi | 0.42220137 |
| 97 | MP0003638_abnormal_response/metabolism_ | 0.42204677 |
| 98 | MP0009384_cardiac_valve_regurgitation | 0.41856099 |
| 99 | MP0005330_cardiomyopathy | 0.41382415 |
| 100 | MP0003300_gastrointestinal_ulcer | 0.40686054 |
| 101 | MP0000230_abnormal_systemic_arterial | 0.39584070 |
| 102 | MP0000579_abnormal_nail_morphology | 0.38899234 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.38857604 |
| 104 | MP0002796_impaired_skin_barrier | 0.38506278 |
| 105 | MP0002060_abnormal_skin_morphology | 0.38417011 |
| 106 | MP0001881_abnormal_mammary_gland | 0.38152997 |
| 107 | MP0000249_abnormal_blood_vessel | 0.37906686 |
| 108 | MP0003091_abnormal_cell_migration | 0.37785812 |
| 109 | MP0002249_abnormal_larynx_morphology | 0.37606575 |
| 110 | MP0005275_abnormal_skin_tensile | 0.37348778 |
| 111 | MP0002896_abnormal_bone_mineralization | 0.36235668 |
| 112 | MP0005503_abnormal_tendon_morphology | 0.36218464 |
| 113 | MP0003329_amyloid_beta_deposits | 0.36081372 |
| 114 | MP0001958_emphysema | 0.36008286 |
| 115 | MP0005452_abnormal_adipose_tissue | 0.35999640 |
| 116 | MP0000467_abnormal_esophagus_morphology | 0.35488234 |
| 117 | MP0000427_abnormal_hair_cycle | 0.33830225 |
| 118 | MP0003646_muscle_fatigue | 0.32807018 |
| 119 | MP0005164_abnormal_response_to | 0.31891265 |
| 120 | MP0002295_abnormal_pulmonary_circulatio | 0.31263147 |
| 121 | MP0004883_abnormal_blood_vessel | 0.30854727 |
| 122 | MP0003075_altered_response_to | 0.30550683 |
| 123 | MP0005595_abnormal_vascular_smooth | 0.30550309 |
| 124 | MP0009053_abnormal_anal_canal | 0.30298253 |
| 125 | MP0009672_abnormal_birth_weight | 0.29806569 |
| 126 | MP0005075_abnormal_melanosome_morpholog | 0.29125237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.07757816 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.84271647 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.63483256 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.15633758 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.03491995 |
| 6 | Xanthomatosis (HP:0000991) | 5.99161402 |
| 7 | Complement deficiency (HP:0004431) | 5.90686716 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.68308116 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.28216713 |
| 10 | Hyperammonemia (HP:0001987) | 4.64331604 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.61506884 |
| 12 | Hyperglycinemia (HP:0002154) | 4.60565316 |
| 13 | Epidermoid cyst (HP:0200040) | 4.59547260 |
| 14 | Joint hemorrhage (HP:0005261) | 4.58434496 |
| 15 | Hyperglycinuria (HP:0003108) | 4.54001708 |
| 16 | Nephritis (HP:0000123) | 4.43397290 |
| 17 | Ketosis (HP:0001946) | 4.39459092 |
| 18 | Hypoglycemic coma (HP:0001325) | 4.36138801 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.36021636 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.30931777 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 4.30931777 |
| 22 | Abnormality of complement system (HP:0005339) | 4.28775915 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.27915869 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 4.10996860 |
| 25 | Fat malabsorption (HP:0002630) | 3.95588854 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.84536789 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.82871291 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.78516674 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 3.76326887 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.68698901 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.63865959 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.52382411 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.52044875 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.51434378 |
| 35 | Ketoacidosis (HP:0001993) | 3.42689115 |
| 36 | Myocardial infarction (HP:0001658) | 3.20525037 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.19346504 |
| 38 | Hypochromic microcytic anemia (HP:0004840) | 3.15896672 |
| 39 | Skin nodule (HP:0200036) | 3.13578198 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.10526622 |
| 41 | Hyperbilirubinemia (HP:0002904) | 3.07333740 |
| 42 | Steatorrhea (HP:0002570) | 2.99284564 |
| 43 | Dicarboxylic aciduria (HP:0003215) | 2.92949833 |
| 44 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.92949833 |
| 45 | Delayed CNS myelination (HP:0002188) | 2.86284126 |
| 46 | Abnormality of nucleobase metabolism (HP:0010932) | 2.85844903 |
| 47 | Metabolic acidosis (HP:0001942) | 2.82815245 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.76328415 |
| 49 | Hepatocellular carcinoma (HP:0001402) | 2.74632126 |
| 50 | Hypoglycemic seizures (HP:0002173) | 2.74479819 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.69094102 |
| 52 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.68427152 |
| 53 | Lethargy (HP:0001254) | 2.60468601 |
| 54 | Spontaneous abortion (HP:0005268) | 2.49680942 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46730069 |
| 56 | Abnormal gallbladder morphology (HP:0012437) | 2.45978202 |
| 57 | Cholelithiasis (HP:0001081) | 2.40815855 |
| 58 | Osteomalacia (HP:0002749) | 2.40438951 |
| 59 | Vascular calcification (HP:0004934) | 2.37959912 |
| 60 | Cerebral edema (HP:0002181) | 2.34557038 |
| 61 | Renal cortical cysts (HP:0000803) | 2.33085387 |
| 62 | Gout (HP:0001997) | 2.30579741 |
| 63 | Mitral stenosis (HP:0001718) | 2.29404427 |
| 64 | Hemorrhage of the eye (HP:0011885) | 2.27172181 |
| 65 | Amyloidosis (HP:0011034) | 2.23377858 |
| 66 | Pancreatitis (HP:0001733) | 2.21823170 |
| 67 | Neonatal onset (HP:0003623) | 2.20720724 |
| 68 | Sensorimotor neuropathy (HP:0007141) | 2.20478817 |
| 69 | Malnutrition (HP:0004395) | 2.17862462 |
| 70 | Cardiovascular calcification (HP:0011915) | 2.17356160 |
| 71 | Generalized aminoaciduria (HP:0002909) | 2.16739094 |
| 72 | Abnormal delivery (HP:0001787) | 2.15501096 |
| 73 | Purpura (HP:0000979) | 2.14181102 |
| 74 | Spastic diplegia (HP:0001264) | 2.13376925 |
| 75 | Vomiting (HP:0002013) | 2.13167515 |
| 76 | Abnormal cartilage morphology (HP:0002763) | 2.12497311 |
| 77 | Cholecystitis (HP:0001082) | 2.12051488 |
| 78 | Abnormal gallbladder physiology (HP:0012438) | 2.12051488 |
| 79 | Acanthocytosis (HP:0001927) | 2.11903896 |
| 80 | Irritability (HP:0000737) | 2.11728822 |
| 81 | Hyperglycemia (HP:0003074) | 2.11698179 |
| 82 | Enlarged kidneys (HP:0000105) | 2.10793582 |
| 83 | Esophageal varix (HP:0002040) | 2.09606549 |
| 84 | Myoglobinuria (HP:0002913) | 2.08618113 |
| 85 | Hypertriglyceridemia (HP:0002155) | 2.08054241 |
| 86 | Glomerulonephritis (HP:0000099) | 2.07915290 |
| 87 | Abnormality of proline metabolism (HP:0010907) | 2.07860631 |
| 88 | Hydroxyprolinuria (HP:0003080) | 2.07860631 |
| 89 | Late onset (HP:0003584) | 2.07401127 |
| 90 | Brushfield spots (HP:0001088) | 2.03175211 |
| 91 | Protrusio acetabuli (HP:0003179) | 1.99027005 |
| 92 | Abnormality of the gallbladder (HP:0005264) | 1.95155931 |
| 93 | Pulmonary embolism (HP:0002204) | 1.94561397 |
| 94 | Joint swelling (HP:0001386) | 1.93932185 |
| 95 | Gingival bleeding (HP:0000225) | 1.93271892 |
| 96 | Elevated alkaline phosphatase (HP:0003155) | 1.92213144 |
| 97 | Neonatal hypoglycemia (HP:0001998) | 1.91751393 |
| 98 | Opisthotonus (HP:0002179) | 1.85766921 |
| 99 | Elevated hepatic transaminases (HP:0002910) | 1.85377110 |
| 100 | Menorrhagia (HP:0000132) | 1.85115497 |
| 101 | Abnormality of the Achilles tendon (HP:0005109) | 1.84947697 |
| 102 | Bile duct proliferation (HP:0001408) | 1.80910272 |
| 103 | Abnormal biliary tract physiology (HP:0012439) | 1.80910272 |
| 104 | Symptomatic seizures (HP:0011145) | 1.80522807 |
| 105 | Abnormality of iron homeostasis (HP:0011031) | 1.79845035 |
| 106 | Rickets (HP:0002748) | 1.79632589 |
| 107 | Proximal tubulopathy (HP:0000114) | 1.77708870 |
| 108 | Reduced antithrombin III activity (HP:0001976) | 1.77495519 |
| 109 | Arthropathy (HP:0003040) | 1.76805076 |
| 110 | Increased mean platelet volume (HP:0011877) | 1.76740565 |
| 111 | Abnormality of vitamin metabolism (HP:0100508) | 1.76257274 |
| 112 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.75410437 |
| 113 | Thrombophlebitis (HP:0004418) | 1.74413936 |
| 114 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.74406057 |
| 115 | Fair hair (HP:0002286) | 1.73483981 |
| 116 | Wrist flexion contracture (HP:0001239) | 1.72565296 |
| 117 | Decreased circulating renin level (HP:0003351) | 1.69901072 |
| 118 | Hyperphosphaturia (HP:0003109) | 1.69786353 |
| 119 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.69683474 |
| 120 | Atrioventricular block (HP:0001678) | 1.68751798 |
| 121 | Enlarged penis (HP:0000040) | 1.67928401 |
| 122 | Bifid scrotum (HP:0000048) | 1.57861457 |
| 123 | Glycosuria (HP:0003076) | 1.55175308 |
| 124 | Abnormality of urine glucose concentration (HP:0011016) | 1.55175308 |
| 125 | Back pain (HP:0003418) | 1.53111251 |
| 126 | Abnormal platelet volume (HP:0011876) | 1.52419158 |
| 127 | Abnormality of carpal bone ossification (HP:0006257) | 1.49369815 |
| 128 | Premature rupture of membranes (HP:0001788) | 1.48314640 |
| 129 | Hypophosphatemic rickets (HP:0004912) | 1.46907233 |
| 130 | Epistaxis (HP:0000421) | 1.46726221 |
| 131 | Periodontitis (HP:0000704) | 1.44930088 |
| 132 | Alkalosis (HP:0001948) | 1.43830511 |
| 133 | Abnormal tarsal ossification (HP:0008369) | 1.42890541 |
| 134 | Aortic aneurysm (HP:0004942) | 1.38201302 |
| 135 | Vertebral compression fractures (HP:0002953) | 1.37014780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.09393795 |
| 2 | SIK1 | 4.60632867 |
| 3 | ERN1 | 4.16907498 |
| 4 | FGFR4 | 3.75338750 |
| 5 | INSRR | 3.58116498 |
| 6 | DDR2 | 2.67855099 |
| 7 | TAOK3 | 2.38094794 |
| 8 | ERBB4 | 2.36116590 |
| 9 | TRIB3 | 2.19624385 |
| 10 | MAP2K4 | 2.01053979 |
| 11 | CAMK1D | 1.99287716 |
| 12 | MST1R | 1.88926737 |
| 13 | ICK | 1.84559322 |
| 14 | LATS1 | 1.83730961 |
| 15 | PIK3CG | 1.83624935 |
| 16 | SCYL2 | 1.60559946 |
| 17 | FLT3 | 1.60333207 |
| 18 | TIE1 | 1.55813932 |
| 19 | MAPK11 | 1.55741278 |
| 20 | PINK1 | 1.52178733 |
| 21 | NEK9 | 1.51884616 |
| 22 | MELK | 1.50362914 |
| 23 | PRKAA2 | 1.47793682 |
| 24 | OBSCN | 1.43645480 |
| 25 | FRK | 1.42184925 |
| 26 | PRPF4B | 1.40530632 |
| 27 | PKN2 | 1.38038214 |
| 28 | FGFR2 | 1.35413894 |
| 29 | MAP3K7 | 1.34405532 |
| 30 | CAMK1G | 1.31580769 |
| 31 | NLK | 1.25949140 |
| 32 | PAK2 | 1.25315746 |
| 33 | TRPM7 | 1.24838494 |
| 34 | IRAK3 | 1.24004851 |
| 35 | TGFBR2 | 1.23419429 |
| 36 | FGFR3 | 1.22157006 |
| 37 | NTRK1 | 1.20389830 |
| 38 | JAK1 | 1.16067114 |
| 39 | TYK2 | 1.15787964 |
| 40 | FER | 1.12027878 |
| 41 | GRK1 | 1.11436488 |
| 42 | RIPK1 | 1.10191415 |
| 43 | PDK4 | 1.09050751 |
| 44 | PDK3 | 1.09050751 |
| 45 | JAK2 | 1.02938798 |
| 46 | STK38L | 1.01552458 |
| 47 | PDGFRB | 1.00944264 |
| 48 | MAP2K3 | 0.98159385 |
| 49 | PTK6 | 0.97772212 |
| 50 | STK38 | 0.97267720 |
| 51 | ABL2 | 0.95625483 |
| 52 | DAPK2 | 0.92938429 |
| 53 | MAPK12 | 0.92378946 |
| 54 | PRKAA1 | 0.92343505 |
| 55 | MAPK7 | 0.90630390 |
| 56 | MAP3K2 | 0.90164399 |
| 57 | GRK6 | 0.86367930 |
| 58 | EPHA3 | 0.82063696 |
| 59 | ERBB2 | 0.79914942 |
| 60 | MAP3K12 | 0.79666306 |
| 61 | CSF1R | 0.77578196 |
| 62 | MOS | 0.76807675 |
| 63 | TTN | 0.76378548 |
| 64 | PRKACG | 0.75563415 |
| 65 | MET | 0.73248739 |
| 66 | LMTK2 | 0.72898742 |
| 67 | SGK3 | 0.72744952 |
| 68 | PHKG2 | 0.72728655 |
| 69 | PHKG1 | 0.72728655 |
| 70 | KDR | 0.71105844 |
| 71 | MAP3K14 | 0.70861509 |
| 72 | MAPK15 | 0.69557273 |
| 73 | MAPK4 | 0.69280169 |
| 74 | MAP3K3 | 0.68119935 |
| 75 | EPHB1 | 0.66377076 |
| 76 | CSK | 0.66233513 |
| 77 | KSR2 | 0.65117917 |
| 78 | PDK2 | 0.64615345 |
| 79 | CDC42BPA | 0.64370458 |
| 80 | GSK3A | 0.64053858 |
| 81 | ZAP70 | 0.63883912 |
| 82 | EEF2K | 0.63697493 |
| 83 | CDK6 | 0.63342985 |
| 84 | PRKCZ | 0.62583878 |
| 85 | PIK3CA | 0.61745116 |
| 86 | CAMK2G | 0.61061932 |
| 87 | PDGFRA | 0.60888134 |
| 88 | CAMKK2 | 0.60574385 |
| 89 | GRK5 | 0.60215641 |
| 90 | AKT2 | 0.59440135 |
| 91 | SGK2 | 0.59203800 |
| 92 | TBK1 | 0.59080243 |
| 93 | IGF1R | 0.58167903 |
| 94 | CAMK4 | 0.57715371 |
| 95 | MAP2K6 | 0.54895605 |
| 96 | PRKCH | 0.52945822 |
| 97 | NTRK3 | 0.52452635 |
| 98 | PKN1 | 0.51876819 |
| 99 | PRKG1 | 0.51048515 |
| 100 | PAK4 | 0.50817491 |
| 101 | PDPK1 | 0.50274997 |
| 102 | MAP3K1 | 0.49711726 |
| 103 | MAPKAPK3 | 0.49599653 |
| 104 | ARAF | 0.47644152 |
| 105 | MAP3K6 | 0.47394086 |
| 106 | IRAK1 | 0.45862396 |
| 107 | MTOR | 0.45597835 |
| 108 | MAP2K1 | 0.45486909 |
| 109 | DYRK1B | 0.43861007 |
| 110 | LATS2 | 0.43542430 |
| 111 | AKT3 | 0.43008711 |
| 112 | MAP3K13 | 0.41477687 |
| 113 | ADRBK2 | 0.40642472 |
| 114 | PRKACA | 0.40524994 |
| 115 | PTK2 | 0.40248861 |
| 116 | CDK12 | 0.40221247 |
| 117 | IRAK2 | 0.39511406 |
| 118 | GRK7 | 0.38330415 |
| 119 | PRKCG | 0.37697569 |
| 120 | PRKG2 | 0.36998103 |
| 121 | MYLK | 0.36468796 |
| 122 | EPHB2 | 0.35490411 |
| 123 | PDK1 | 0.33206996 |
| 124 | TAOK2 | 0.32946217 |
| 125 | SGK494 | 0.32922356 |
| 126 | SGK223 | 0.32922356 |
| 127 | PRKCQ | 0.32714391 |
| 128 | SRC | 0.32622798 |
| 129 | ZAK | 0.32612209 |
| 130 | PRKD2 | 0.31746497 |
| 131 | PRKD1 | 0.29733121 |
| 132 | SGK1 | 0.29420011 |
| 133 | MAP3K5 | 0.29395391 |
| 134 | RPS6KA3 | 0.29085404 |
| 135 | EIF2AK2 | 0.28394694 |
| 136 | RET | 0.28119557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.45887049 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.30829411 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.04739823 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.97600124 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.84290871 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.81682112 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.72378177 |
| 8 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69187103 |
| 9 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.63908211 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63192090 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.57283679 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.38765938 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.34134713 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.25585049 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20230701 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.20077565 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.17820726 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.15006305 |
| 19 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00527535 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.99572279 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94233725 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87584575 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.86919496 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80020915 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73838919 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69893968 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.69762545 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66141635 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60882821 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58839932 |
| 31 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.56514024 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55018029 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50763934 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.50672495 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47778365 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.44531337 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.44301843 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.42716602 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.39205138 |
| 40 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33911171 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.32835583 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.26640140 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25582588 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21007581 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.07151586 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06834428 |
| 47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.05738742 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04385082 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.03968057 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.96890142 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96306253 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92706367 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 0.88659042 |
| 54 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87970750 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86936686 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84756525 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83467660 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82892272 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77358232 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72187836 |
| 61 | * Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69753134 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64582850 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62675225 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.56249679 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56092441 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53919427 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47406369 |
| 68 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46066305 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.44322501 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.41880349 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38515046 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38409619 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36067676 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35034023 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29268823 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26455858 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25059233 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24065666 |
| 79 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.21855836 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17562919 |
| 81 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.13185167 |
| 82 | Other glycan degradation_Homo sapiens_hsa00511 | 0.12657787 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.09551514 |
| 84 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.07742916 |
| 85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.05483368 |
| 86 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.02620598 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.02193470 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.01650223 |
| 89 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.01544140 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.00938236 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2144531 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2098655 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2086074 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2043198 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1688907 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1674238 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | -0.1615454 |
| 98 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.1555658 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1548822 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1545723 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | -0.1544542 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.1376606 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1336977 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1238168 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0894630 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0859265 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0780148 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0725142 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0697347 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0607897 |
| 111 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0580258 |
| 112 | * Vitamin B6 metabolism_Homo sapiens_hsa00750 | -0.0558995 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | -0.0272859 |
| 114 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0178700 |
| 115 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0016474 |

